Vertex Pharmaceuticals (VRTX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to -$1.6 billion.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments fell 1401.76% to -$1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 billion, marking a year-over-year decrease of 1401.76%. This contributed to the annual value of $771.6 million for FY2024, which is 5961.27% down from last year.
- Latest data reveals that Vertex Pharmaceuticals reported Other Gross PP&E Adjustments of -$1.6 billion as of Q3 2025, which was down 1401.76% from -$1.3 billion recorded in Q2 2025.
- Over the past 5 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments peaked at $1.9 billion during Q4 2023, and registered a low of -$1.6 billion during Q3 2025.
- In the last 5 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$322.3 million in 2021 and averaged -$189.2 million.
- In the last 5 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 2170.59% in 2021 and then crashed by 34962.96% in 2024.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $1.5 billion in 2021, then increased by 11.27% to $1.7 billion in 2022, then increased by 14.82% to $1.9 billion in 2023, then tumbled by 59.61% to $771.6 million in 2024, then tumbled by 306.3% to -$1.6 billion in 2025.
- Its Other Gross PP&E Adjustments was -$1.6 billion in Q3 2025, compared to -$1.3 billion in Q2 2025 and -$1.3 billion in Q1 2025.